Industry
Life Science
SDG is a leading authority in guiding life science enterprises through the intricate terrain of today’s ever-changing landscape. Armed with a spectrum of expertise spanning from early research & development to commercialization and sustained life cycle management, we empower our life science partners to navigate with confidence.
Within an industry marked by swift evolution, our role is pivotal in assisting executives in evaluating the potential of new assets and disruptive platforms and technologies while optimizing their R&D portfolios.
Projects completed
of the 20 top-tier Pharma Companies
work with SDG
Our Services
Corporate Strategy
- Business Model Design
- Strategic Footprint & Direction
Portfolio Strategy
- Long-Term Portfolio Strategy
- Portfolio Management & Optimization
Therapy Area & Franchise Strategy
- Therapy Area/Franchise Expansions
- Disease Assessment & Forecasting
Product Strategy & Evolution
- Product Development Strategy
- Market Assessment & Forecasting
Valuation & Risk Analysis
- Asset Valuation
- Strategic Scenario & Risk Analysis
Licensing/Partnering
- M&A Strategy
- Commercial Due Diligence
Partner & Practice Lead Global Life Science and Europe Consulting
Duesseldorf, Germany
“In life sciences, we excel at dissecting complex challenges, offering inventive solutions tailored to navigate the industry’s unique intricacies with efficiency and expertise.’’
Featured Insights
Read more insights from our experts.
- Webinar
The Importance of Portfolio Strategy in an Era of Real-Time Portfolio Management
- Video
Indication Sequencing in Pharma
- Publications
Supporting Innovation in Early-Stage Pharmaceutical Development Decisions
- Publications
Mitigating Biases in Pharmaceutical R&D Decision-Making
- Video
Portfolio Strategy for a Global Pharmaceutical Company
- Case Study
Multi-Attribute Portfolio Prioritization Fosters Alignment on Strategy
- Case Study
Cutting-edge Prioritization Model Enables Consistent Evaluation of Early-stage Drugs Across Pharma Portfolio
Webinars
Explore further insights from our experts by checking out our webinars.
- Webinar
Toward Superforecasting®: Lessons from the Eli Lilly Probability Assessment Panel
- Webinar
The Importance of Portfolio Strategy in an Era of Real-Time Portfolio Management
- Webinar
A New Approach to Early-Stage Portfolio Decision-Making
Case Studies
Discover more insights from our experts by delving into our case studies.
- Case Study
Search for Medtech Growth Strategy Reveals Most Promising Amid Rich Set of Opportunities
- Case Study
Risk Assessment of Curtailing Clinical Trial Saves Life Sciences Company $36 Million
- Case Study
Rapid, Transparent Evaluation Helps ‘Stuck’ Biotech Board Resolve Debate over Promising Cancer Therapy
- Case Study
Pharmaceutical Company Requires Nimble Development Strategy When Faced with Unforeseen Challenges
- Case Study
Novel, Forward-Looking Planning Tool Allows Management to Anticipate and Reverse Inventory Buildup
- Case Study
Multi-Attribute Portfolio Prioritization Fosters Alignment on Strategy
- Case Study
Identifying Maximum Capacity Value, Strategy for Life Sciences Manufacturing Company
- Case Study
Forward-Looking Planning Tool Allows Management to Anticipate—and Reverse—Inventory Buildup
- Case Study
Developing a MedTech Growth Strategy
- Case Study
Developing a Decision-Making Framework for a Life Sciences Company’s Product Launch
- Case Study
Cutting-edge Prioritization Model Enables Consistent Evaluation of Early-stage Drugs Across Pharma Portfolio
- Case Study